SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Liesl Eibschutz, a medical student from Dartmouth University, loads a syringe with the Pfizer Covid-19 vaccine at Kedren Health in Los Angeles, California on April 15, 2021. (Photo: Allen J. Schaben/Los Angeles Times via Getty Images)
FDA Panel Recommends Pfizer Booster Shots for People 65+ and Especially Vulnerable
The scientific advisory committee voted down a recommendation for other adults.
Sep 17, 2021
A Food and Drug Administration advisory panel on Friday unanimously recommended booster shots of the Pfizer Covid-19 vaccine for U.S. adults age 65 and older, and those especially at risk from virus, while voting strongly against recommending the same for people between the ages of 16 and 64.
Though neither vote is binding, the agency is likely to follow the advice of the 18-member committee and is expected to issue a final decision on boosters--a topic of controversy in recent months, especially given the ongoing global inequity in terms of access to vaccines--as early as next week.
According to the Associated Press:
The decision was made by a committee of outside experts who advise the Food and Drug Administration.
In a surprising turn, the panel first rejected, by a vote of 16-2, boosters for nearly everyone.
Members cited a lack of safety data on extra doses and also raised doubts about the value of mass boosters, rather than ones targeted to specific groups. Then, in an 18-0 vote, it endorsed the extra shot for select portions of the U.S. population--namely, those most at risk from the virus.
While the Biden administration had set a public goal of enacting a booster program for all U.S. adults this fall, there has been consistent pushback from the scientific community over whether the evidence supported the need for such a sweeping policy.
"It's unclear that everyone needs to be boosted, other than a subset of the population that clearly would be at high risk for serious disease," Dr. Michael G. Kurilla, a committee member and official at the National Institutes of Health, told the New York Times.
Dr. Ashish Jha, the dean of the Brown University School of Public Health, welcomed the panel's position, tweeting Friday that it is "clearly consistent with the evidence and this outcome should never have been in doubt."
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
A Food and Drug Administration advisory panel on Friday unanimously recommended booster shots of the Pfizer Covid-19 vaccine for U.S. adults age 65 and older, and those especially at risk from virus, while voting strongly against recommending the same for people between the ages of 16 and 64.
Though neither vote is binding, the agency is likely to follow the advice of the 18-member committee and is expected to issue a final decision on boosters--a topic of controversy in recent months, especially given the ongoing global inequity in terms of access to vaccines--as early as next week.
According to the Associated Press:
The decision was made by a committee of outside experts who advise the Food and Drug Administration.
In a surprising turn, the panel first rejected, by a vote of 16-2, boosters for nearly everyone.
Members cited a lack of safety data on extra doses and also raised doubts about the value of mass boosters, rather than ones targeted to specific groups. Then, in an 18-0 vote, it endorsed the extra shot for select portions of the U.S. population--namely, those most at risk from the virus.
While the Biden administration had set a public goal of enacting a booster program for all U.S. adults this fall, there has been consistent pushback from the scientific community over whether the evidence supported the need for such a sweeping policy.
"It's unclear that everyone needs to be boosted, other than a subset of the population that clearly would be at high risk for serious disease," Dr. Michael G. Kurilla, a committee member and official at the National Institutes of Health, told the New York Times.
Dr. Ashish Jha, the dean of the Brown University School of Public Health, welcomed the panel's position, tweeting Friday that it is "clearly consistent with the evidence and this outcome should never have been in doubt."
A Food and Drug Administration advisory panel on Friday unanimously recommended booster shots of the Pfizer Covid-19 vaccine for U.S. adults age 65 and older, and those especially at risk from virus, while voting strongly against recommending the same for people between the ages of 16 and 64.
Though neither vote is binding, the agency is likely to follow the advice of the 18-member committee and is expected to issue a final decision on boosters--a topic of controversy in recent months, especially given the ongoing global inequity in terms of access to vaccines--as early as next week.
According to the Associated Press:
The decision was made by a committee of outside experts who advise the Food and Drug Administration.
In a surprising turn, the panel first rejected, by a vote of 16-2, boosters for nearly everyone.
Members cited a lack of safety data on extra doses and also raised doubts about the value of mass boosters, rather than ones targeted to specific groups. Then, in an 18-0 vote, it endorsed the extra shot for select portions of the U.S. population--namely, those most at risk from the virus.
While the Biden administration had set a public goal of enacting a booster program for all U.S. adults this fall, there has been consistent pushback from the scientific community over whether the evidence supported the need for such a sweeping policy.
"It's unclear that everyone needs to be boosted, other than a subset of the population that clearly would be at high risk for serious disease," Dr. Michael G. Kurilla, a committee member and official at the National Institutes of Health, told the New York Times.
Dr. Ashish Jha, the dean of the Brown University School of Public Health, welcomed the panel's position, tweeting Friday that it is "clearly consistent with the evidence and this outcome should never have been in doubt."
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.